{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T16:01:37Z","timestamp":1762444897888,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.4158\/ep-2019-0122","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T17:11:24Z","timestamp":1559841084000},"page":"869-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Opportunistic Evaluation of Bone Mineral Density By Pet-Ct in Hodgkin Lymphoma Patients"],"prefix":"10.1016","volume":"25","author":[{"given":"Bar","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurith","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auryan","family":"Szalat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Vainstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0122_bb0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/annonc\/mdt560","article-title":"Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study","volume":"25","author":"Paccou","year":"2014","journal-title":"Ann Oncol"},{"key":"10.4158\/EP-2019-0122_bb0015","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0002-9343(88)90504-9","article-title":"Bone mineralization in women following successful treatment of Hodgkin's disease","volume":"85","author":"Redman","year":"1988","journal-title":"Am J Med"},{"key":"10.4158\/EP-2019-0122_bb0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/bjc.1994.308","article-title":"Reduced bone mineral density in men following chemotherapy for Hodgkin's disease","volume":"70","author":"Holmes","year":"1994","journal-title":"Br J Cancer"},{"key":"10.4158\/EP-2019-0122_bb0025","first-page":"3013","article-title":"Bone loss and hematological malignancies in adults: a pilot study","volume":"26","author":"Ruchlemer","year":"2018","journal-title":"Support Care Cancer"},{"key":"10.4158\/EP-2019-0122_bb0030","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(02)08761-5","article-title":"Diagnosis of osteoporosis and assessment of fracture risk","volume":"359","author":"Kanis","year":"2002","journal-title":"Lancet"},{"key":"10.4158\/EP-2019-0122_bb0035","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/jbmr.428","article-title":"Simultaneous screening for osteoporosis at CT colonography: bone mineral density assessment using MDCT attenuation techniques compared with the DXA reference standard","volume":"26","author":"Pickhardt","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.4158\/EP-2019-0122_bb0040","doi-asserted-by":"crossref","first-page":"588","DOI":"10.7326\/0003-4819-158-8-201304160-00003","article-title":"Opportunistic screening for osteoporosis using abdominal computed tomography scans obtained for other indications","volume":"158","author":"Pickhardt","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP-2019-0122_bb0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/annonc\/mdu044","article-title":"Bone mineral density screening should be routine in lymphoma patients","volume":"25","author":"Thompson","year":"2014","journal-title":"Ann Oncol"},{"key":"10.4158\/EP-2019-0122_bb0050","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1007\/s00198-018-4669-4","article-title":"Bone management in hematologic stem cell transplant recipients","volume":"29","author":"Kendler","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.4158\/EP-2019-0122_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev.immunol.24.021605.090646","article-title":"Osteoimmunology: interplay between the immune system and bone metabolism","volume":"24","author":"Walsh","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"10.4158\/EP-2019-0122_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"10.4158\/EP-2019-0122_bb0065","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/1097-0142(20011101)92:9<2419::AID-CNCR1591>3.0.CO;2-K","article-title":"High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: a mechanism for post-bone marrow transplantation osteopenia","volume":"92","author":"Banfi","year":"2001","journal-title":"Cancer"},{"key":"10.4158\/EP-2019-0122_bb0070","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1136\/bmj.285.6355.1612","article-title":"Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy","volume":"285","author":"Waxman","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.4158\/EP-2019-0122_bb0075","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.amjmed.2003.12.019","article-title":"Effect of pamidronate on new vertebral fractures and bone mineral density in patients with malignant lymphoma receiving chemotherapy","volume":"116","author":"Kim","year":"2004","journal-title":"Am J Med"},{"key":"10.4158\/EP-2019-0122_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.clml.2012.11.002","article-title":"Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial","volume":"13","author":"Westin","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.4158\/EP-2019-0122_bb0085","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jocd.2015.06.013","article-title":"Executive summary of the 2015 ISCD position development conference on advanced measures from DXA and QCT: fracture prediction beyond BMD","volume":"18","author":"Shepherd","year":"2015","journal-title":"J Clin Densitom"},{"key":"10.4158\/EP-2019-0122_bb0090","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1080\/10428194.2016.1233543","article-title":"R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients","volume":"58","author":"Svendsen","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.4158\/EP-2019-0122_bb0095","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrrheum.2014.188","article-title":"Glucocorticoid-induced osteoporosis: who to treat with what agent?","volume":"11","author":"Rizzoli","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.4158\/EP-2019-0122_bb0100","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.1158\/1078-0432.CCR-08-1026","article-title":"Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma","volume":"14","author":"Biggar","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2035179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:07:08Z","timestamp":1761516428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2035179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1530891X2035179X"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0122","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunistic Evaluation of Bone Mineral Density By Pet-Ct in Hodgkin Lymphoma Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}